Michael Hüll

14.9k citations
42 papers · 1.6k · 1 hit paper · h-index 18

Impact in

Papers in

    • Inflammatory mediators and NSAID effects 7
    • Cholinesterase and Neurodegenerative Diseases 5
    • Alzheimer's disease research and treatments 10

Michael Hüll

38 papers receiving 1.6k citations

Michael Hüll's Hit Papers

A Phase II Trial of Tideglusib in Alzheimer's Disease 2015 · 417 citations
4170+3+7Years since publication100200300400

Peers

Michael Hüll
Comparison fields: 5 of 103
  • Neurology 318
  • Biological Psychiatry 72
  • Physiology 638
  • Pharmacology 331
  • Psychiatry and Mental health 206
Replace Alessia Maddalena with:
Alessia Maddalena Switzerland
Francesca Colciaghi Italy
Yasushi Tomidokoro Japan
Nikunj Patel United States
Paige E. Cramer United States
Chang‐En Yu United States
Susan Raju United States
Hanna Rosenmann Israel
Konstantinos Vekrellis United States
Yang Chang United States
Michael Hüll relative to Alessia Maddalena Switzerland Alessia Maddalena's profile →
Citations per field
00.5×12×
Alessia Maddalena · 1×
Citations per year

Countries citing papers authored by Michael Hüll

Since Specialization
Citations

This map shows the geographic impact of Michael Hüll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hüll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hüll more than expected).

Fields of papers citing papers by Michael Hüll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hüll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hüll. The network helps show where Michael Hüll may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Hüll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hüll Line = papers co-authored together Michael Hüll links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Phase II Trial of Tideglusib in Alzheimer's Disease
Hit paper breakdown →
2015417
2 2006201
3 2005121
4 200985
5 199782
6 200777
7 200871
8 199655
9 201749
10 200043
11 200642
12 200941
13 200340
14 200535
15 199631
16 201528
17 200627
18 202221
19 201816
20 201416

About Michael Hüll

Michael Hüll is a scholar working on Pharmacology, Physiology, Molecular Biology, Neurology and Psychiatry and Mental health, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (10 papers), Inflammatory mediators and NSAID effects (7 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Dementia and Cognitive Impairment Research (5 papers), Neuroscience and Neuropharmacology Research (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Neurology (318 citations), Biological Psychiatry (72 citations), Physiology (638 citations), Pharmacology (331 citations) and Psychiatry and Mental health (206 citations). Michael Hüll has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Bernd L. Fiebich, Klaus Lieb, Johannes C. M. Schlachetzki, Eduardo Candelario‐Jalil, Teodoro del Ser, Simon Lovestone, Teresa León, Bruno Dubois, Miguel Calero and Merçé Boada. Their work appears in journals such as Journal of Neurochemistry, Current Alzheimer Research, Alzheimer s & Dementia, Glia and Neuroreport.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact